ArticleFrontiers in oncology2022

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer.

Sahyun Pak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.